New next-generation cell therapy manufacturing facility that will support 500 skilled biomanufacturing jobs and more than 4,000 construction jobs during the site's development. Expanded details for a project first announced in January 2026.

Part of a larger, previously announced $55 billion company investment.

A new injectable medicine and device manufacturing facility that will produce next-generation weight-loss therapies. The project will bring 850 high-value jobs to the Lehigh Valley area, including engineers, scientists, operations personnel and lab technicians.

Part of a larger, previously announced $27 billion company investment.

An expansion of Genentech’s (Roche’s U.S. subsidiary) initial $700 million investment in a new fill-finish biologics plant, bringing the total investment in this facility to $2 billion.

The expanded investment will include additional production capacity and support an additional 100 new jobs once completed.

Part of a larger, previously announced $50 billion company investment.

Pledging an additional $90 billion toward U.S.-based research and development and capital investments, including manufacturing, over the next decade to bring the company’s total commitment to $100 billion.

AbbVie previously committed to a $10 billion U.S. expansion in April 2025.

A new radioligand therapy (RLT) manufacturing site is expected to come online by 2029 and strengthen the company’s specialized supply chain and manufacturing capabilities across its network of RLT production facilities.

Part of a larger, previously announced $23 billion company investment.

Two new manufacturing facilities will be built in North Carolina and Pennsylvania, the latter with a focus on next-generation cell therapy.

Part of a larger, previously announced $55 billion company investment

A new, next-generation active pharmaceutical ingredient (API) facility that will support the production of small molecule synthetic and peptide medicines, including an oral GLP-1. The project will bring “450 high-value jobs” to the area, including engineers, scientists, operations personnel and lab technicians, and 3,000 construction jobs.

Part of a larger, previously announced $27 billion company investment.

An expansion of the India-based company's existing Fall River facility. Will include an 83,000-square-foot addition to increase the company’s production capacity and operational efficiency.